Navigation Links
Questcor Provides Updated New Paid Prescription Trends
Date:9/10/2011

form Act of 1995. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "believes," "continue," "could," "estimates," "expects," "growth," "may," "plans," "potential," "should," "substantial" or "will" or the negative of such terms and other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the following:

  • Our reliance on Acthar for substantially all of our net sales and profits;
  • Reductions in vials used per prescription resulting from changes in treatment regimens by physicians or patient compliance with physician recommendations;
  • The complex nature of our manufacturing process and the potential for supply disruptions or other business disruptions;
  • The lack of patent protection for Acthar; and the possible FDA approval and market introduction of competitive products;
  • Our ability to generate revenue from sales of Acthar to treat on-label indications associated with NS, and our ability to develop other therapeutic uses for Acthar;
  • Research and development risks, including risks associated with Questcor's preliminary work in the area of nephrotic syndrome and our reliance on third-parties to conduct research and development and the ability of research and development to generate successful results;
  • Regulatory changes or other policy actions by governmental authorities and other third parties as recently adopted U.S. health care reform legislation is implemented;
  • Our ability to receive high reimbursement levels from third party payers;
  • An increase in the proportion of our Acthar unit sales comprised of Medicaid-eligible patients and government entities;
  • Our ability to estimate reserves required for Act
    '/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
2. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
3. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
4. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
5. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
6. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
7. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
8. Questcor Pharmaceuticals to Present at the Needham Healthcare Conference
9. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
10. Questcor Pharmaceuticals Selects BDO USA as its Auditor
11. Questcor Reports 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 2015   Mallinckrodt Pharmaceuticals (NYSE: MNK ... it has extended the deadline for submitting applications to ... The program awards grants to help fund projects in ... Research Fellowship Awards program is designed to further scientific ... will award a total of 25 positions. The program ...
(Date:5/26/2015)... 2015  Over the past several years, numerous studies ... a sleeve gastrectomy, and weight loss surgery in ... recently, a study conducted by Italian researchers and published ... that obese patients suffering from an overactive bladder tend ... losing weight with a laparoscopic sleeve gastrectomy. This is ...
(Date:5/26/2015)... -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ) ("the Company"), ... that address unmet medical needs in women,s health, ... will present at the Marcum MicroCap Conference as ... PM EDTLocation: , The Grand Hyatt, New York, ... ,Investor, or  click here The webcast ...
Breaking Medicine Technology:Mallinckrodt Extends Deadline For 2015 Research Fellowship Program 2Mallinckrodt Extends Deadline For 2015 Research Fellowship Program 3Add Overactive Bladder Syndrome to the List of Conditions Shown to Be Improved by a Sleeve Gastrectomy 2Juniper Pharmaceuticals to Present at Investor Conference on May 28, 2015 2
... ROSA, Calif., March 12 Northern California Foot,and ... recruiting patients with,lower extremity diabetic foot ulcers to ... trial will study the effects of Excellarate(TM),(GAM501) (Ad5PDGF-B/bovine ... patients with neuropathic non-healing diabetic foot ulcers. Excellarate,is ...
... with Education & ... ... Journal of,the American Medical Association on the largest weight loss maintenance,study ... both personal contact and web-based support are,identified as the key to ...
Cached Medicine Technology:Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial 2Study Finds Personal and Web-Based Support Equal Weight Loss Success 2Study Finds Personal and Web-Based Support Equal Weight Loss Success 3Study Finds Personal and Web-Based Support Equal Weight Loss Success 4
(Date:5/26/2015)... May 26, 2015 Mr. Gould and Mr. ... will start working together this week to ensure a smooth ... in healthcare executive leadership and strategy. Gary is familiar ... the hiring of Mr. Cochran. The Board of Trustees believe ... the improvement strategies implemented over the past few years. ...
(Date:5/26/2015)... 2015 Neeta Pai was diagnosed with ... fainting spells, four of which landed her in the ... , Though she still struggles with anemia, iron ... her time to increasing HHT awareness and garnering support ... awareness, we could have prevented all the heartbreak and ...
(Date:5/26/2015)... Portland, OR (PRWEB) May 26, 2015 Sexual ... and while Title IX is best known for creating opportunities ... universities accountable for sexual assault response and prevention. In a ... Greene of Global Sports Advocates explains what Title IX ... schools can get in front of this issue to protect ...
(Date:5/26/2015)... 26, 2015 3,000 senior industry executives ... and debate the future of the connected car. A ... steering wheel that can read a driver’s brain waves. ... a driving simulator by mind alone just by gripping ... Logic said: “We are working on cognitive load, altering ...
(Date:5/26/2015)... 2015 Relias Learning , the ... health and human services market, announces expansion of their ... strong attendance and participation in 2014, they will double ... annual user conference an exciting new facelift. , ... together and discuss best practices, share their expertise, provide ...
Breaking Medicine News(10 mins):Health News:Rochester Woman Brings Awareness to Genetic Disease 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 3Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3
... hailed by researchers for its ability to target cancer cells ... ON01910 works by interfering with a molecule known as Plk1, ... This molecule is found in higher numbers in cancerous tumors, ... especially high amounts. ,The drug was tested on ...
... says that mercury pollution in the state of Texas in US ... of autistic children. ,In US, mercury is released in ... to the researchers, on an average, for each 1000 pounds of ... in the rate of autism with 43% increase in the rates ...
... Buffalo University dental researchers have identified some proteins that ... current drugs that are used to treat fungal infections ... anti-fungal properties, even against fungal infections that become resistant ... be increased if they can be protected from the ...
... A recent study says that oil from the fishes contains ... like Mackerel and Salmon, if are taken in a diet ... people with cardiovascular disease and arthritis. In case of absence ... also do the trick. ,Trials have shown previously that ...
... with heart attack calm disease progression but do not help ... be a potential source for regeneration of heart function and ... in this regard. , This has been explained by ... an emerging source for treatment of diseased hearts. However, implanting ...
... a panic disorder may benefit more from treatment combining ... care usually offered by physicians. ,Panic disorder is ... In the study, 232 patients meeting the criteria for ... usual or a treatment combining medication and up to ...
Cached Medicine News:
Taber's Cyclopedic Medical Dictionary has definitions and information they need to provide care for their patients....
Taber's Cyclopedic Medical Dictionary is published by F.A. Davis. Contains approximately 56,000 terms....
Dorland's includes terms of the Terminologia Anatomica on your Palm or Pocket PC PDA or Smartphone....
Stedmans Medical Dictionary is a PDA reference for nursing and allied health professionals and students....
Medicine Products: